Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cheerslife Technology, officially known as Shanghai Qisheng Biological Technology Co., Ltd., is a leading Chinese biotechnology firm specializing in the development and manufacture of medical biomaterials. As a core subsidiary of the publicly traded Shanghai Haohai Biological Technology, the company focuses on four primary therapeutic sectors: ophthalmology, orthopedics, medical aesthetics, and surgical anti-adhesion. Its extensive product portfolio includes medical sodium hyaluronate (hyaluronic acid) and medical chitosan, which are widely utilized in cataract surgeries, osteoarthritis management, and as dermal fillers. Cheerslife operates state-of-the-art manufacturing facilities that comply with international GMP standards and maintains a dominant market share in the Chinese domestic market. The company is recognized for its innovation in absorbable biomaterials and its commitment to advancing the clinical application of viscoelastic agents and tissue engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cheerslife Technology.